Safety and Mortality: Monitoring the Patients on Rivaroxaban

EFFICACY AND SAFETY OUTCOMES OF RIVAROXABAN IN ACUTE DEEP VENOUS THROMBOSIS PATIENTS

Efficacy and Safety of Low Dose Rivaroxaban in Patients with Anterior Myocardial Infarction

Comparative study of safety and effectiveness of rivaroxaban and warfarin in patients with acute deep venous thrombosis

Short Term Evaluation of Warfarin Versus Rivaroxaban Regimens in the Treatment of Deep Venous Thrombosis

Rivaroxaban versus Warfarin in Treatment of Acute Lower Limb Deep Venous Thrombosis and its Affection on Quality of Life.

XANTUS-EL: A Real-World, Prospective, Observational Study of Patients Treated With Rivaroxaban For Stroke Prevention In Atrial Fibrillation In Eastern Europe, Middle East, Africa

Healthcare Effect and Safety of Patients with Persistent Non-Valvular Atrial Fibrillation Using NOAC and Warfarin

Oral rivaroxaban for postoperative prophylaxis of venous thromboembolism after sleeve gastrectomy in patients with morbid obesity, is it safe: A prospective randomized clinical t

Comparative Study between Rivaroxaban and Warfarin inTreatment of Patients with Recurrent Deep Venous Thrombosis